PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 152 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $399,000 | -25.4% | 105,125 | 0.0% | 0.00% | -100.0% |
Q4 2019 | $535,000 | +0.8% | 105,125 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $531,000 | -18.2% | 105,125 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $649,000 | -30.3% | 105,125 | -50.1% | 0.00% | 0.0% |
Q1 2019 | $931,000 | +110.2% | 210,550 | +99.7% | 0.00% | 0.0% |
Q4 2018 | $443,000 | -32.8% | 105,425 | +0.3% | 0.00% | 0.0% |
Q3 2018 | $659,000 | -37.8% | 105,125 | -20.3% | 0.00% | 0.0% |
Q2 2018 | $1,060,000 | -53.2% | 131,861 | -56.6% | 0.00% | -66.7% |
Q1 2018 | $2,266,000 | +25.4% | 303,692 | 0.0% | 0.00% | +50.0% |
Q4 2017 | $1,807,000 | -2.5% | 303,692 | +20.5% | 0.00% | -33.3% |
Q3 2017 | $1,854,000 | +68.4% | 251,930 | +55.4% | 0.00% | +50.0% |
Q2 2017 | $1,101,000 | +19.4% | 162,122 | +66.1% | 0.00% | +100.0% |
Q1 2017 | $922,000 | +35.0% | 97,632 | +23.5% | 0.00% | 0.0% |
Q4 2016 | $683,000 | +0.1% | 79,028 | -26.6% | 0.00% | 0.0% |
Q3 2016 | $682,000 | -9.5% | 107,663 | -23.3% | 0.00% | 0.0% |
Q2 2016 | $754,000 | +10.4% | 140,361 | +0.1% | 0.00% | 0.0% |
Q1 2016 | $683,000 | -20.5% | 140,191 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $859,000 | +80.5% | 140,191 | +68.4% | 0.00% | +100.0% |
Q3 2015 | $476,000 | – | 83,250 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|